journal article·2024-06

X‐Ray‐Triggered CO‐Release from Gold Nanocluster: All‐in‐One Nanoplatforms for Cancer Targeted Gas and Radio Synergistic Therapy

Lei Cao, Yating Yang, Yanlin Zheng, Wei Cheng, Minghong Chen, Tongtong Wang, Chuan Mu, Min Wu, Bin Liu

Advanced Materials· Volume 36· Issue 25
Publisher page

Abstract

Abstract Glycolysis‐dominant metabolic pathway in cancer cells can promote their therapeutic resistance against radiotherapy (RT). Carbon monoxide (CO) as a glycolysis inhibitor can enhance the efficiency of RT. Herein, an X‐ray responsive CO‐releasing nanocomposite (HA@AuNC@CO) based on strong host–guest interactions between the radiosensitizer and CO donor for enhanced RT is developed. The encapsulated gold nanoclusters (CD‐AuNCs) can effectively generate cytotoxic reactive oxygen species (ROS) under X‐ray radiation, which not only directly inactivate cancer cells but also induce in situ CO gas generation from adamantane modified metal carbonyl (Ada‐CO) for glycolysis inhibition. Both in vitro and in vivo results demonstrate that HA@AuNC@CO exhibits active targeting toward CD44 overexpressed cancer cells, along with excellent inhibition of glycolysis and efficient RT against cancer. This study offers a new strategy for the combination of gas therapy and RT in tumor treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Heme Oxygenase-1 and Carbon Monoxide · Nanoplatforms for cancer theranostics · Hemoglobin structure and function

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Joint School of National University of Singapore and Tianjin University International Campus of Tianjin University Fuzhou 350207 P. R. China

Department of Chemical and Biomolecular Engineering National University of Singapore Singapore 117585 Singapore

MOE Key Laboratory for Analytical Science of Food Safety and Biology College of Chemistry Fuzhou University Fuzhou 350108 P. R. China

Funding

National University of Singapore · National Research Foundation Singapore · National Natural Science Foundation of China

References (49)

Show source-provided references
1. Schaue D. · Clin. Oncol. · 2015 · 12 · 527
2. 10.1039/D3MH00265A10.1039/D3MH00265A ↗
3. 10.1021/acsnano.6b0140110.1021/acsnano.6b01401 ↗
4. 10.1038/nrc300710.1038/nrc3007 ↗
5. 10.7150/ijms.363510.7150/ijms.3635 ↗
6. 10.1002/adma.20170099610.1002/adma.201700996 ↗
7. 10.1039/D1SC03997K10.1039/D1SC03997K ↗
8. 10.1016/j.cclet.2022.02.04910.1016/j.cclet.2022.02.049 ↗
9. 10.1186/s12951-022-01694-110.1186/s12951-022-01694-1 ↗
10. 10.3390/ijms2403260610.3390/ijms24032606 ↗
11. 10.1021/acs.nanolett.2c0247210.1021/acs.nanolett.2c02472 ↗
12. 10.1016/j.mtnano.2022.10025310.1016/j.mtnano.2022.100253 ↗
13. 10.1038/nrd322810.1038/nrd3228 ↗
14. 10.1002/smll.20190438210.1002/smll.201904382 ↗
15. 10.2174/13892011280039932910.2174/138920112800399329 ↗
16. 10.1016/j.canlet.2022.21583110.1016/j.canlet.2022.215831 ↗
17. 10.1002/anie.20230252510.1002/anie.202302525 ↗
18. 10.1002/1873-3468.1243410.1002/1873-3468.12434 ↗
19. 10.1158/0008-5472.CAN-13-107510.1158/0008-5472.CAN-13-1075 ↗
20. 10.1038/s41467-019-09158-110.1038/s41467-019-09158-1 ↗
21. 10.1016/j.biomaterials.2023.12231310.1016/j.biomaterials.2023.122313 ↗
22. 10.1002/anie.20221167410.1002/anie.202211674 ↗
23. 10.1113/jphysiol.1912.sp00151710.1113/jphysiol.1912.sp001517 ↗
24. 10.1002/adtp.20180008410.1002/adtp.201800084 ↗
25. 10.1021/jacs.7b0086710.1021/jacs.7b00867 ↗
26. 10.1002/adma.20180196410.1002/adma.201801964 ↗
27. 10.1039/C5BM00210A10.1039/C5BM00210A ↗
28. 10.1021/ja00513a01910.1021/ja00513a019 ↗
29. 10.1021/ja00356a04710.1021/ja00356a047 ↗
30. 10.1021/ic902147n10.1021/ic902147n ↗
31. 10.2147/IJN.S39825410.2147/IJN.S398254 ↗
32. 10.1039/C7MH00451F10.1039/C7MH00451F ↗
33. 10.2147/IJN.S27290210.2147/IJN.S272902 ↗
34. 10.1002/anie.20201087010.1002/anie.202010870 ↗
35. 10.1039/C6CP02770A10.1039/C6CP02770A ↗
36. 10.1002/anie.20200103410.1002/anie.202001034 ↗
37. 10.1039/C4CC04533E10.1039/C4CC04533E ↗
38. 10.1021/es061780010.1021/es0617800 ↗
39. 10.1039/C7CC01576C10.1039/C7CC01576C ↗
40. 10.1126/sciadv.aba136210.1126/sciadv.aba1362 ↗
41. 10.1038/s41557-018-0055-210.1038/s41557-018-0055-2 ↗
42. 10.1021/acs.nanolett.7b0138210.1021/acs.nanolett.7b01382 ↗
43. 10.1021/acsami.8b0920010.1021/acsami.8b09200 ↗
44. 10.1021/acs.analchem.7b0013510.1021/acs.analchem.7b00135 ↗
45. 10.1002/adma.20150276210.1002/adma.201502762 ↗
46. 10.1007/s11051-018-4324-110.1007/s11051-018-4324-1 ↗
47. 10.1021/acs.molpharmaceut.9b0008310.1021/acs.molpharmaceut.9b00083 ↗
48. 10.1007/s00018-019-03398-610.1007/s00018-019-03398-6 ↗
49. Queiroga C. S. F. · Biochem. Res. Int. · 2014 · 2012